BioVaxys Technology Corp.
BVAXF
$0.0229
$0.00031.33%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.01% | 62.53% | -131.93% | -116.79% | -204.17% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 412.93% | -106.50% | 23.57% | 11,555.56% | 101.27% |
| Change in Net Operating Assets | 240.39% | 102.22% | 126.22% | -643.33% | -72.50% |
| Cash from Operations | 99.09% | 15.54% | -147.08% | 6.52% | -17,988.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -200.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | 10.61% | 13.42% | 2.37% | 1.14% | -25.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.64% | 11.03% | -1.11% | 7.08% | -28.89% |
| Foreign Exchange rate Adjustments | 188.71% | -348.00% | 2,600.00% | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.20% | 81.26% | -184.53% | 140.74% | -183.11% |